CLINICAL_TRIALS
trial_result
· 2013-07-04
Clinical Trial Update: Open-Label Extension Study of Kuvan for Autism [Phase 2, Phase 3]
Summary
Open-label extension study of Kuvan (sapropterin dihydrochloride) in autism completed with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Children's Health Council | Conditions: Autistic Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-07-04